The latest report on cancer among African-Americans shows a good-news, bad-news scenario. While racial gaps are closing for some types of cancers, including fewer cancer deaths among African-American men, disparities are increasing for some cancers that can be found through routine screenings.
The latest data show that the cancer death rate declined faster for African-American men than among white men during the latest time period.“The decline is greater for black males because they started with higher rates of deaths and especially greater rates of preventable deaths,” said Dr. Otis Brawley, chief medical officer of the American Cancer Society. All races have shown declines in deaths beginning in 1991, Brawley said. The declines in black men were first noticed in 1999. Brawley says the decline shows success in cancer prevention.
Smoking cessation in the 1960s and 1970s made a big impact. Brawley also notes the importance of getting adequate treatment to the African-American population. Decreasing disparities in care is a reason for the drop, but Brawley notes that “as in smoking cessation, we can do better.”
African-American males have higher incidence rates than whites for all cancers combined (15% higher) and for the most common cancers (including prostate, lung, colorectal, kidney, and pancreas), according to the American Cancer Society. But African-American females have lower overall incidence rates than whites for all cancers combined (6% lower) and for many cancers, including the two most common: breast and lung. Cancer death rates remain 33% higher among African-American men than white men. Cancer death rates among African-American women are 16% higher than among white women. "These disparities reflect unequal access to health care and other socioeconomic factors," Brawley said.
Despite some progress, the report reveals that while racial gaps are closing for some cancers, including lung and smoking-related cancers and for prostate cancer, the racial disparity has increased for colorectal cancer and female breast cancers.